|  | Duration (day) |  |  |
---|---|---|---|---|
Parameter | Groups | 0 | 14 | 28 |
PCV (%) | Control | 38.40 ± 0.5a1 | 40.20 ± 0.37a2 | 46.00 ± 0.84a3 |
150 mgkg−1 O3FA | 41.20 ± 0.37b1 | 43.60 ± 0.68b2 | 51.40 ± 0.75b3 | |
 | 250 mgkg−1 O3FA | 40.80 ± 0.37b1 | 42.80 ± 0.49b2 | 51.60 ± 0.68b3 |
RBC (× 106cells/μl) | Control | 7.30 ± 0.07a1 | 7.32 ± 0.07a1 | 7.32 ± 0.07a1 |
150 mgkg−1 O3FA | 7.24 ± 0.08a1 | 7.27 ± 0.07a1 | 7.29 ± 0.05a1 | |
250 mgkg−1 O3FA | 7.26 ± 0.05a1 | 7.27 ± 0.05a1 | 7.27 ± 0.042a1 | |
Hb (g/dl) | Control | 12.80 ± 0.81a1 | 13.39 ± 0.13a2 | 15.33 ± 0.28a3 |
150 mgkg−1 O3FA | 13.73 ± 0.13b1 | 14.53 ± 0.23b2 | 17.13 ± 0.25b3 | |
 | 250 mgkg−1 O3FA | 13.60 ± 0.13b1 | 14.27 ± 0.16b2 | 17.20 ± 0.23b3 |
WBC (× 103/μl) | Control | 8.92 ± 0.02a1 | 9.00 ± 0.03a2 | 9.03 ± 0.04a2 |
150 mgkg−1 O3FA | 8.97 ± 0.02a1 | 9.00 ± 0.01a2 | 9.03 ± 0.02a2 | |
 | 250 mgkg−1 O3FA | 8.96 ± 0.03a1 | 9.01 ± 0.02a2 | 9.05 ± 0.03a2 |
MCV (fl) | Control | 52.61 ± 0.42a1 | 55.10 ± 0.98a2 | 63.00 ± 0.70a3 |
150 mgkg−1 O3FA | 56.63 ± 0.94b1 | 59.76 ± 1.28b1 | 70.25 ± 1.35b2 | |
 | 250 mgkg−1 O3FA | 56.05 ± 0.46b1 | 58.80 ± 0.80b2 | 70.88 ± 0.94b3 |
MCH (pg) | Control | 17.54 ± 0.14a1 | 18.17 ± 0.33a1 | 20.94 ± 0.24a2 |
150 mgkg−1 O3FA | 18.88 ± 0.32b1 | 19.92 ± 0.42b1 | 23.42 ± 0.45b1 | |
 | 250 mgkg−1 O3FA | 18.72 ± 0.14b1 | 19.62 ± 0.26b2 | 23.65 ± 0.30b3 |
MCHC (g/dl) | Control | 33.34 ± 0.00a1 | 33.30 ± 0.02a1 | 33.33 ± 0.00a1 |
150 mgkg−1 O3FA | 33.33 ± 0.00a1 | 33.33 ± 0.00a1 | 33.33 ± 0.00a1 | |
 | 250 mgkg−1 O3FA | 33.34 ± 0.00a1 | 33.30 ± 0.02a1 | 33.33 ± 0.00a1 |